Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending
1. Revvity forecasts 2025 profit and revenue below Wall Street estimates. 2. Company expects soft demand for products in drug research.
FAQ
Why Bearish?
Lower profit and revenue forecasts indicate weak performance, potentially leading to a decrease in stock value.
How important is it?
Forecast impacts overall investor sentiment, especially significant given recent financial performance.
Why Short Term?
Immediate impact expected as investors react to disappointing forecasts, reminiscent of past quarterly earnings drops.